Trial NCT04126343

View at ClinicalTrials.gov 
Org. Study IDs: UP0050
Secondary IDs: 2019-002797-31

Last trial update was posted on 2021-06-18

MeSH Interventions

Moxifloxacin Padsevonil

MeSH Conditions


Other Conditions

Healthy Study Participants

Stopping Reasons

Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID